Getein Biotech Market Cap

Getein Biotech has a market cap or net worth of 4.08 billion as of April 24, 2025. Its market cap has decreased by -11.06% in one year.

Market Cap

4.08B

Enterprise Value

3.79B

Revenue

1.25B

Ranking

n/a

PE Ratio

16.09

Stock Price

8.04

Market Cap Chart

Since July 17, 2017, Getein Biotech's market cap has decreased from 4.23B to 4.08B, a decrease of -3.59%. That is a compound annual growth rate of -0.47%.

Market Cap History

Date	Market Cap	% Change
Apr 24, 2025	4.08B	-2.55%
Dec 31, 2024	4.18B	-25.00%
Dec 29, 2023	5.58B	-12.00%
Dec 30, 2022	6.34B	-12.61%
Dec 31, 2021	7.25B	-18.60%
Dec 31, 2020	8.91B	48.48%
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Jiangsu Hengrui Medicine	325.11B
Shenzhen Mindray Bio-Medical Electronics	262.70B
WuXi AppTec	162.00B
Zhangzhou Pientzehuang Pharmaceutical.,	123.71B
Aier Eye Hospital Group	116.59B
Sichuan Biokin Pharmaceutical	113.68B
Shanghai United Imaging Healthcare	103.27B
Yunnan Baiyao Group Co.,Ltd	102.86B

Market Cap Rankings